Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 5/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14716575 | 0.82 | FGFR1 (0.58) | PNPFGFR1FGFR2 | |
| SCHEMBL14716514 | 0.82 | FGFR1 (0.48) | PNPFGFR1FGFR2 | |
| SCHEMBL14716709 | 0.80 | TYMS (0.41) | PNP | |
| SCHEMBL12321218 | 0.80 | TYMS (0.41) | PNP | |
| SCHEMBL1301998 | 0.71 | PNP (0.68) | PNPFGFR1FGFR2 | |
| SCHEMBL874735 | 0.70 | PNP (0.66) | PNPFGFR1FGFR2 | |
| SCHEMBL14716410 | 0.69 | FGFR1 (0.46) | PNPFGFR1FGFR2 | |
| 8-Aminoguanine SCHEMBL21761 | 0.68 | PNP (1.00) | PNPFGFR1FGFR2 | |
| SCHEMBL3303807 | 0.68 | PNP (0.77) | PNPFGFR1FGFR2 | |
| SCHEMBL10339631 | 0.67 | PNP (0.61) | PNPFGFR1FGFR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458515-B2 | RNA including nucleoside compound, method for regulating amount of protein produced from the RNA, and nucleoside compound | RIKEN (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20130052710-A1 | RNA INCLUDING NUCLEOSIDE COMPOUND, METHOD FOR REGULATING AMOUNT OF PROTEIN PRODUCED FROM THE RNA, AND NUCLEOSIDE COMPOUND | RIKEN (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052710-A1 | RNA INCLUDING NUCLEOSIDE COMPOUND, METHOD FOR REGULATING AMOUNT OF PROTEIN PRODUCED FROM THE RNA, AND NUCLEOSIDE COMPOUND | RNMT, NSUN2, RNGTT | PNP 22/4885FGFR1 4325/4885FGFR2 4803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.